Moderna can take months to ship Omicron-specific vaccine, CEO says on CNBC

Moderna Inc may take months to start delivery a COVID-19 vaccine that works particularly towards the Omicron variant, its chief government officer, Stéphane Bancel, informed CNBC on Monday.

The Omicron variant carries a really excessive world threat of surges, the WHO warned on Monday, as extra nations reported circumstances.

Bancel informed CNBC in an interview that the efficacy of COVID-19 vaccines towards the variant was at present not recognized, and that there needs to be extra readability in about two weeks.

Moderna mentioned on Friday it was working to advance a booster candidate tailor-made to the brand new variant and has additionally been testing a better dose of its current booster and to review different booster candidates designed to guard towards a number of variants.

Individually, rivals Pfizer and BioNTech, and Johnson & Johnson have additionally mentioned they’ve begun testing their vaccines towards the brand new variant.

See also  Good variety of sick days needn't make your child uninteresting